S.T. Genesis

About Speransa Therapeutics

Speransa Therapeutics is a private, commercial-stage biotech company founded in 2018 and headquartered in Cambridge, Massachusetts. The company has developed and is commercializing the S.T. Genesis, an FDA-cleared, wearable neurostimulation device applied to the outer ear to alleviate symptoms of opioid withdrawal over a five-day period. Its business model centers on the distribution and support of this medical device, targeting the substantial market need for non-pharmacological opioid use disorder (OUD) treatment aids. The company appears to be in an early revenue-generating phase, focusing on provider adoption, reimbursement support, and patient access.

Therapeutic Areas